Juniper Pharmaceuticals Inc (NASDAQ:JNP)

9.15
Delayed Data
As of Apr 19
 0.00 / 0.00%
Today’s Change
3.75
Today|||52-Week Range
13.25
+88.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues11.2M14.0M13.0M11.8M
 
 
 
 
 
Cost of Goods Sold6.1M7.1M7.1M6.4M
 
 
 
 
 
Depreciation And Amortization484.0K591.0K593.0K600.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.7M6.3M5.3M4.8M
 
 
 
 
 
General Expenses6.1M6.7M6.0M5.3M
 
 
 
 
 
Research And Development1.3M1.6M2.3M1.6M
 
 
 
 
 
Total Operating Expenses12.7M14.3M13.8M12.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.5M-356.0K-779.0K-496.0K
 
 
 
 
 
Extraordinary Charge0.000.00-756.0K-21.0K
 
 
 
Interest Expense On Debt28.0K30.0K47.0K25.0K
 
 
 
 
 
Other Expenses42.0K10.0K127.0K1.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.4M-376.0K-1.5M1.0M
 
 
 
 
 
Income Taxes0.000.00-45.0K-141.0K
 
 
 
Preferred Dividend-7.0K-452.0K0.000.00
 
 
 
Net Income-1.4M-376.0K-1.4M1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.8M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted10.8M11.0M10.8M11.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.03-$0.13$0.11
 
 
 
 
 
EPS Diluted-$0.13-$0.03-$0.13$0.11